Clinical trial · Interventional
Auris Robotic Endoscopy System for Bronchoscopy
A Single-Center, Prospective, Single Arm Study to Evaluate the Performance of the Auris Robotic Endoscopy System for Bronchoscopic Procedures
NCT03497026CI-TRIAL-00055037terminatedN/AResults postedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Mutual Termination
Summary
Brief summary (as posted)
In this study, the performance related to the use of the novel Robotic Endoscopy Platform during bronchoscopic procedures will be evaluated.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Robotic Bronchoscopy Platform | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Robotic Bronchoscopy
- description
- Robotic bronchoscopy with Robotic Bronchoscopy Platform
- interventionNames
- Device: Robotic Bronchoscopy Platform
Primary outcomes (1)
- measure
- Number of Participants Who Completed the Intended Bronchoscopic Procedure With the Robotic Endoscopy Platform
- timeFrame
- During the procedure, up to 2 hours
- description
- Completion of the intended bronchoscopic procedure is defined by the ability to acquire tissue with biopsy tools.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: 1. 18 to 80 years of age; 2. Capable and willing to give informed consent; 3. Acceptable candidate for an elective, non-emergent bronchoscopic procedure; 4. Solid peripheral lung lesions suspected of malignancy, between 1.5-7cm in size identified on thin slice CT scan with 30 days of the intended bronchoscopy Exclusion Criteria: 1. Medical contraindication to bronchoscopy; 2. Ground glass opacity lesions on pre-procedure CT 3. Participation in any other clinical trial 30 days before and throughout the duration of the study; 4. Uncontrolled or irreversible coagulopathy; 5. Female subjects who are pregnant or nursing or those of child-bearing potential refusing a pregnancy test; 6. CT scan done over a month before the bronchoscopy procedure. Intra-Procedure Exclusion Criteria: Any presenting condition discovered intra-procedurally that in the opinion of the investigator would make participating in this study not in the patient's best interest.
References
Publications (0)
Data not yet available
No reference posted for this study.